-Advertisement-
-Advertisement-
Oncology
Positive outcomes possible for patients who stop immune checkpoint inhibitor treatment
Patients with cancer who stop receiving PD-1/PD-L1 immune checkpoint inhibitor (ICI) treatment after achieving sustained disease control (SDC) can still experience positive outcomes, according to a retrospective study. The study, which analyzed electronic health records of 204 cancer patients treated with ICI between 2014 and 2021, found that 44 patients...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
Contact
© 2024 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved